UNSPSC 51162316: Acetaminophen/chlorpheniramine/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF) which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162316 Acetaminophen/chlorpheniramine/pseudoephedrine is a Commodity code that in recent state and local procurement activity covers pharmaceutical products and over-the-counter medications sourced through cooperative purchasing agreements and individual jurisdiction procurements. State and local governments soliciting under this code include county health departments, state purchasing offices administering multistate cooperative vehicles, and health facility networks seeking pharmaceutical inventory for community health initiatives and clinical operations. The scope of work encompasses supply agreements for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers, with vendors required to maintain current Good Manufacturing Practices certification, Drug Supply Chain Security Act compliance, and contractual relationships with established pharmaceutical distribution networks. Issuing bodies range from single counties managing direct procurement for community health programs to multistate cooperative purchasing alliances coordinating supply across participating jurisdictions in multiple states.

Recent activity centers on cooperative purchasing vehicles and county health procurement. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products with a response deadline of March 26, 2026, seeking manufacturers to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health 110 and 112, and Morris & Dickson Co., LLC) with contracts effective July 1, 2026 and participation extending across participating states including Oregon. Seminole County, Florida, solicited an IFB (IFB60459723LAS) on June 30, 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to its Community Health Building, with a response deadline of July 26, 2023. Geographic activity appears concentrated in states with active multistate cooperative procurement programs and individual county health systems, with Minnesota and Florida representing recent issuing jurisdictions. The MMCAP cooperative vehicle indicates broader participation across multiple states, while individual county solicitations suggest continued direct procurement at the jurisdiction level for health-support products and community health initiatives.